Navigation Links
Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
Date:6/2/2008

istered as 30mg/m2 per day for five consecutive days then, based on their response, received up to five additional cycles of treatment at a dose of 20 mg/m2 per day for five consecutive days.

Significant Unmet Medical Need

The CLASSIC II study is designed to address a high unmet medical need among older AML patients who currently have limited treatment options. According to the American Cancer Society, each year approximately 6,500 people over the age of 60 are diagnosed with AML in the U.S. The median survival for those receiving therapy can vary from one to thirteen months, and the five-year survival rate over the past three decades remains at less than 10 to 15 percent. Older AML patients often have disease features such as unfavorable (adverse) cytogenetics and pre-existing blood disorders such as MDS that result in lower response rates and worse treatment outcomes to conventional induction chemotherapy compared with younger patients. In addition, conventional induction chemotherapy is poorly tolerated in older patients with unfavorable risk factors, and early induction mortality usually ranges from 10-30 percent but can exceed 30 percent in older patients with a poor performance status.

This study builds on promising results from two prior studies of single agent clofarabine in previously untreated older patients with AML deemed unfit for chemotherapy, based mostly on poor performance status and presence of co-morbid illnesses. These studies were conducted by Alan Burnett, M.D., of Cardiff University in the United Kingdom and presented at earlier American Society of Hematology meetings.

Clolar Clinical Development

A separate, phase 3 pivotal study (CLASSIC I) of clofarabine in relapsed adult AML patients aged 55 and older and previously treated with at least one, but not more than two, prior induction regimens is underway. This randomized, double-blind, placebo-controlled study will compare the combination of clofarabine and c
'/>"/>

SOURCE Genzyme Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
3. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
4. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
5. Pharmion and MethylGene Report Preliminary MGCD0103 Clinical Data at the 2007 AACR-NCI-EORTC International Conference
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting
8. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
9. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
10. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
11. A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... , July 21, 2014  AVT, Inc. ... in automated retailing, micro-stores, custom vending machines and ... their automated medicine dispensing systems, which can be ... clinics and marijuana dispensaries. AVT,s newly designed systems ... of medicines and regulated products. "We ...
(Date:7/21/2014)... 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... Administration (FDA) accepted the company,s Investigational New Drug (IND) ... and efficacy of AVP-786, Avanir,s next generation compound. The ... the adjunctive treatment of major depressive disorder (MDD) during ... "The endorsement of this Phase II study by the ...
(Date:7/21/2014)... July 21, 2014   Aventura , the leader ... announced today that MemorialCare Health System , ... computing solution at the Orange Coast Memorial ... Orange Coast Memorial is a 218-bed ... 12,000 patients annually. The Aventura Roaming Aware Desktop ...
Breaking Medicine Technology:Technology Driving Cannabis Industry 2Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 3MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 4
... Patent Office has awarded COPAN the much awaited patent for ... samples. This grant, deriving from a very thorough and careful ... flocked swab invention. COPAN,s revolutionary invention has now been awarded ...   " We are thrilled to receive ...
... -- The Ministry of Health and Welfare (Minister ... Institute (President Ko Kyung-hwa) launched a project to ... by designating 38 tasks, including seven major issues ... injuries and granting permission for drug dispensing in ...
Cached Medicine Technology:US Patent Office Grants COPAN Invention of Flocked Swabs 2Medical Korea's Medical Policy Improvement Project for Foreign Patients 2
(Date:7/22/2014)... Get Real Health announced today ... (IDF) to provide their patient community with a ... to electronically track their symptoms, medications and other health-related ... also allow those patients and families who want ... data shared with the U.S. Immunodeficiency Network (USIDNET) ...
(Date:7/22/2014)... July 22, 2014 Atreo Services will ... service and support programs and accessories in booth #1423 ... Conference & Technical Exhibition in Chicago, Ill., Aug. 3-6. ... pneumatic tube system carriers as well as its selection ... brand-name hospital tube systems. In addition, representatives will ...
(Date:7/22/2014)... Altec Products, Inc. , a leader ... their Gold Sponsorship of Sage Summit 2014 ... and Casino in Las Vegas, Nevada. The largest educational ... in taking advantage of the many opportunities to network ... and educate themselves on the latest enterprise resource planning ...
(Date:7/22/2014)... Dr. Allen Kamrava, colorectal surgeon in Beverly ... new website dedicated to the diagnosis and treatment of ... DrKamrava.com . , “With this new website, I ... trustworthy source for various colorectal conditions ,” says ... colon cancer, hernias, or more, patients will find that ...
(Date:7/22/2014)... FL (PRWEB) July 22, 2014 ... opened registration for multiple upcoming real estate investing workshops ... potentially life-changing events are designed to introduce people to ... in the Canadian market. , A total of 9 ... a period of three weeks. The goal is to ...
Breaking Medicine News(10 mins):Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:Atreo Services to Introduce Pneumatic Tube System Solutions at ASHE Annual Conference 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 2Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 3Health News:Brick Buy Brick Announces Multiple 1-Day Real Estate Workshops Coming to Toronto 2
... Calif., April 1, 2008 MAQUET Cardiovascular,LLC ... infringement complaints,in the United States International Trade ... District of Northern California against Terumo Corporation,and ... that,Terumo infringes two MAQUET U.S. patents through ...
... have found that community health center-trained family physicians were ... non-community health center-trained counterparts (64 percent versus 37 percent), ... of Family Medicine. The news comes on the heels ... Program that there is an increased interest in family ...
... College of Cardiology during,ceremonies at the 57th Annual ... CHICAGO, April 1, 2008 Robert O. Bonow, ... Northwestern Memorial Hospital, and Goldberg Distinguished Professor of,Northwestern ... the,American College of Cardiology (ACC) as Master of ...
... 1, 2008 Faced with shrinking,staffs and less ... time serving the hospital marketplace. As their time,to ... for the,pharma industry are turning to other decision-makers ... formularies, according to research from benchmarking,leader Best Practices, ...
... for Heightened Autism Awareness among Hispanic Community as Fewer ... Receiving Diagnosis and Support, ... its services for individuals living with autism, among the,vast array of ... ones., Over the last 20 years, Easter Seals has seen ...
... Co-Chairs and Leading Grassroots Autism Association Push,for Services ... The United,Nations has designated April 2 as World ... Autism Society of America, the World Autism,Organization and ... Research and Education (C.A.R.E.), Rep. Chris Smith and ...
Cached Medicine News:Health News:MAQUET Cardiovascular Announces Patent Infringement Complaints Against Terumo 2Health News:Want docs to treat the underserved? Make sure they train at community health centers 2Health News:Robert Bonow, MD Honored for Outstanding Service by the American College of Cardiology 2Health News:Robert Bonow, MD Honored for Outstanding Service by the American College of Cardiology 3Health News:Effectively Influencing the Hospital Marketplace to Win a Place on Formularies 2Health News:Easter Seals Notes April's Autism Awareness Month to Highlight Services Available to Families Living With Autism 2Health News:Easter Seals Notes April's Autism Awareness Month to Highlight Services Available to Families Living With Autism 3Health News:Reps. Smith and Doyle, Autism Society of America Push Landmark Legislation on World Autism Awareness Day 2Health News:Reps. Smith and Doyle, Autism Society of America Push Landmark Legislation on World Autism Awareness Day 3
... facilitates real time information collection. It ... first module is a software link ... the database where information is captured ... the user interface, which allows access ...
... provides a solution for instantaneously locating ... or unauthorized movement of patients or ... key concern. Certain patients, such as ... patients with highly communicable diseases, patients ...
... PDC Smart™ Labels have a direct ... Texas Instruments Tag-it™ HF-I transponder. When ... codes, text and other graphics may ... variable data is programmed to the ...
PDC RFID Smart™ Cards can be printed and programmed using a dye-sublimation card printer & programmer....
Medicine Products: